您的位置: 首页 > 农业专利 > 详情页

COMBINATION THERAPY WITH ICOS AGONIST AND OX40 AGONIST TO TREAT CANCER
专利权人:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
Christopher B. HOPSON,David J. KILIAN,Patrick A. MAYES,Sapna YADAYILLI,Niranjan YANAMANDRA
申请号:
US16620694
公开号:
US20200190195A1
申请日:
2018.06.08
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention provides a combination of an anti-ICOS antibody or antigen binding portion thereof and an anti-OX40 antibody or antigen binding portion thereof. The present invention also provides method of treating cancer in a patient in need thereof comprising administering to the patient an effective amount of an anti-ICOS antibody and an effective amount of an anti-OX40 antibody or antigen binding portion thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充